Horizons Ventures

Nourish Ingredients is a food tech company based in Canberra, Australia, founded in 2019. The company specializes in creating animal fat molecules through proprietary precision fermentation, allowing for the mass production of these fats without involving animals. This innovative approach enables the development of alternative proteins that replicate the flavor, smell, and cooking experience of traditional animal fats. By providing these potent fat molecules, Nourish Ingredients aims to enhance the taste and quality of plant-based products, catering to consumers seeking delicious and authentic alternatives to meat.

Soul Machines Limited, founded in 2016 and headquartered in Auckland, New Zealand, specializes in the development of emotionally responsive avatars that enhance user experiences across various artificial intelligence platforms. The company offers a range of products, including the Digital DNA Studio, which allows users to create custom digital avatars for applications in customer care, marketing, education, and more. By utilizing its innovative Biological AI technology and patented Digital Brain™, Soul Machines aims to humanize AI, creating engaging and empathetic AI assistants that facilitate deeper interactions and personalized experiences. With additional offices in major cities worldwide, including San Francisco, New York, London, Tokyo, and Melbourne, Soul Machines is at the forefront of transforming customer engagement through ethical and responsive human-machine collaboration.

Harrison.ai is a clinician-led healthcare AI company based in Barongarook, Victoria, Australia, founded in 2018. The company specializes in using deep learning technology to enhance the success rates of in vitro fertilization (IVF) for patients. By developing AI-enabled tools that seamlessly integrate into existing clinical workflows, Harrison.ai aims to empower healthcare providers and improve patient outcomes. Its proprietary IVY deep learning model analyzes comprehensive video feeds from embryo scopes, outperforming traditional AI tools that rely on still images. Harrison.ai combines deep learning expertise with clinical experience to address significant challenges in healthcare, focusing on the continuous innovation and commercialization of efficient and affordable healthcare products and services.

Q-CTRL is a pioneering company in the quantum technology sector, focused on addressing critical challenges related to hardware error and instability. By developing advanced quantum control infrastructure software, Q-CTRL supports research and development professionals as well as end users in quantum computing, facilitating the transition to practical quantum computers. The company's innovative "Software-defined" quantum sensors are tailored for applications in defence, intelligence, navigation, and earth observation. With a team of expert quantum-control engineers, Q-CTRL collaborates with leading universities, national laboratories, and industry partners worldwide. As a notable member of the IBM Quantum Startup network and various industry consortia, Q-CTRL is recognized for its contributions to the field and has received several prestigious awards, including those from the Modern Manufacturing Initiative and the Next Generation Technology Fund. The company has garnered attention in major publications and was ranked among the Top 10 Most Innovative Tech Companies in Australia, highlighting its role in shaping the future of quantum technology.

Fleet Space Technologies is an Australian space technology company specializing in a constellation of commercial micro-satellites. The company has developed the world's first 3D printed all-metal patch antenna for space, significantly enhancing the throughput of its spacecraft. Fleet Space aims to transform critical mineral discovery, space exploration, and defense by utilizing its satellite-enabled systems and seismic array technology. Their innovative approach facilitates low-cost satellite-based solutions for Industrial Internet of Things applications, enabling clients to effectively explore for critical minerals globally and connect various celestial bodies, including Earth, the Moon, and Mars.

Prospection is a prominent health insights company that specializes in healthcare data analytics, employing predictive analytics and machine learning to extract valuable insights from real-world healthcare data. Established in 2012 in Sydney, Prospection collaborates with government entities, pharmaceutical companies, and the medical community across a wide range of therapy programs, including immuno-oncology, diabetes, respiratory diseases, HIV, and hepatitis, operating in regions such as Australia, Japan, the Asia Pacific, the UK, and the USA. The company offers a software-as-a-service (SaaS) platform that transforms healthcare data into actionable insights, analyzing longitudinal patient data, geo-mapping, and medication utilization. This enables healthcare clients, including pharmaceutical manufacturers and research institutions, to enhance drug performance and improve patient outcomes through innovative data analytics solutions.

V2food is a plant-based meat startup based in Sydney, New South Wales, Australia, founded in 2019 by Nick Hazell. The company specializes in producing legume-based meat alternatives aimed at providing a nutritious and delicious option for individuals who enjoy the taste of meat but prefer not to consume animal products. V2food's offerings emphasize natural ingredients that are rich in protein, energy, fiber, and essential amino acids, promoting a sustainable approach to food consumption. The products are designed to minimize greenhouse gas emissions, land degradation, and biodiversity loss, making them an eco-friendly choice for consumers seeking to foster positive relationships with food while contributing to a more sustainable planet.

Nourish Ingredients is a food tech company based in Canberra, Australia, founded in 2019. The company specializes in creating animal fat molecules through proprietary precision fermentation, allowing for the mass production of these fats without involving animals. This innovative approach enables the development of alternative proteins that replicate the flavor, smell, and cooking experience of traditional animal fats. By providing these potent fat molecules, Nourish Ingredients aims to enhance the taste and quality of plant-based products, catering to consumers seeking delicious and authentic alternatives to meat.

Prospection is a prominent health insights company that specializes in healthcare data analytics, employing predictive analytics and machine learning to extract valuable insights from real-world healthcare data. Established in 2012 in Sydney, Prospection collaborates with government entities, pharmaceutical companies, and the medical community across a wide range of therapy programs, including immuno-oncology, diabetes, respiratory diseases, HIV, and hepatitis, operating in regions such as Australia, Japan, the Asia Pacific, the UK, and the USA. The company offers a software-as-a-service (SaaS) platform that transforms healthcare data into actionable insights, analyzing longitudinal patient data, geo-mapping, and medication utilization. This enables healthcare clients, including pharmaceutical manufacturers and research institutions, to enhance drug performance and improve patient outcomes through innovative data analytics solutions.

Soul Machines Limited, founded in 2016 and headquartered in Auckland, New Zealand, specializes in the development of emotionally responsive avatars that enhance user experiences across various artificial intelligence platforms. The company offers a range of products, including the Digital DNA Studio, which allows users to create custom digital avatars for applications in customer care, marketing, education, and more. By utilizing its innovative Biological AI technology and patented Digital Brain™, Soul Machines aims to humanize AI, creating engaging and empathetic AI assistants that facilitate deeper interactions and personalized experiences. With additional offices in major cities worldwide, including San Francisco, New York, London, Tokyo, and Melbourne, Soul Machines is at the forefront of transforming customer engagement through ethical and responsive human-machine collaboration.

Q-CTRL is a pioneering company in the quantum technology sector, focused on addressing critical challenges related to hardware error and instability. By developing advanced quantum control infrastructure software, Q-CTRL supports research and development professionals as well as end users in quantum computing, facilitating the transition to practical quantum computers. The company's innovative "Software-defined" quantum sensors are tailored for applications in defence, intelligence, navigation, and earth observation. With a team of expert quantum-control engineers, Q-CTRL collaborates with leading universities, national laboratories, and industry partners worldwide. As a notable member of the IBM Quantum Startup network and various industry consortia, Q-CTRL is recognized for its contributions to the field and has received several prestigious awards, including those from the Modern Manufacturing Initiative and the Next Generation Technology Fund. The company has garnered attention in major publications and was ranked among the Top 10 Most Innovative Tech Companies in Australia, highlighting its role in shaping the future of quantum technology.

Fleet Space Technologies is an Australian space technology company specializing in a constellation of commercial micro-satellites. The company has developed the world's first 3D printed all-metal patch antenna for space, significantly enhancing the throughput of its spacecraft. Fleet Space aims to transform critical mineral discovery, space exploration, and defense by utilizing its satellite-enabled systems and seismic array technology. Their innovative approach facilitates low-cost satellite-based solutions for Industrial Internet of Things applications, enabling clients to effectively explore for critical minerals globally and connect various celestial bodies, including Earth, the Moon, and Mars.

Q-CTRL is a pioneering company in the quantum technology sector, focused on addressing critical challenges related to hardware error and instability. By developing advanced quantum control infrastructure software, Q-CTRL supports research and development professionals as well as end users in quantum computing, facilitating the transition to practical quantum computers. The company's innovative "Software-defined" quantum sensors are tailored for applications in defence, intelligence, navigation, and earth observation. With a team of expert quantum-control engineers, Q-CTRL collaborates with leading universities, national laboratories, and industry partners worldwide. As a notable member of the IBM Quantum Startup network and various industry consortia, Q-CTRL is recognized for its contributions to the field and has received several prestigious awards, including those from the Modern Manufacturing Initiative and the Next Generation Technology Fund. The company has garnered attention in major publications and was ranked among the Top 10 Most Innovative Tech Companies in Australia, highlighting its role in shaping the future of quantum technology.

Medasense is a company specializing in pain monitoring technology aimed at optimizing and personalizing pain management for patients. Its flagship product, the PMD-200, utilizes a proprietary non-invasive sensor platform and artificial intelligence to objectively monitor and quantify a patient's pain response through the NOL® index. This device is particularly beneficial in operating rooms and critical care settings where patients cannot communicate, addressing a significant market need. Medasense also offers pipeline cloud-based solutions that leverage NOL technology for use in clinics and home care, targeting an even larger global market. The PMD-200 is distributed in Europe by Medtronic and has received clearance for marketing in Canada, Latin America, and Australia, with capabilities for integration with Philips patient monitors. Clinical studies have highlighted its effectiveness in improving patient safety and outcomes while reducing opioid usage. Founded in 2008, Medasense is headquartered in Ramat Gan, Tel Aviv, Israel.